These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16617070)

  • 1. A computational framework for the topological analysis and targeted disruption of signal transduction networks.
    Dasika MS; Burgard A; Maranas CD
    Biophys J; 2006 Jul; 91(1):382-98. PubMed ID: 16617070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological analysis of mass-balanced signaling networks: a framework to obtain network properties including crosstalk.
    Papin JA; Palsson BO
    J Theor Biol; 2004 Mar; 227(2):283-97. PubMed ID: 14990392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we identify cellular pathways implicated in cancer using gene expression data?
    Shah N; Lepre J; Tu Y; Stolovitzky G
    Proc IEEE Comput Soc Bioinform Conf; 2003; 2():94-103. PubMed ID: 16452783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An empirical Bayes approach to inferring large-scale gene association networks.
    Schäfer J; Strimmer K
    Bioinformatics; 2005 Mar; 21(6):754-64. PubMed ID: 15479708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering distinct functional modules of specific cancer types using protein-protein interaction networks.
    Shen R; Wang X; Guda C
    Biomed Res Int; 2015; 2015():146365. PubMed ID: 26495282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.
    Naldi A; Larive RM; Czerwinska U; Urbach S; Montcourrier P; Roy C; Solassol J; Freiss G; Coopman PJ; Radulescu O
    PLoS Comput Biol; 2017 Mar; 13(3):e1005432. PubMed ID: 28306714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting targets for therapeutic validation through differential protein expression using chromatography-mass spectrometry.
    Patterson S
    Bioinformatics; 2002; 18 Suppl 2():S181. PubMed ID: 12386001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intervention in context-sensitive probabilistic Boolean networks.
    Pal R; Datta A; Bittner ML; Dougherty ER
    Bioinformatics; 2005 Apr; 21(7):1211-8. PubMed ID: 15531600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topological estimation of signal flow in complex signaling networks.
    Lee D; Cho KH
    Sci Rep; 2018 Mar; 8(1):5262. PubMed ID: 29588498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mathematical model of combination therapy using the EGFR signaling network.
    Araujo RP; Petricoin EF; Liotta LA
    Biosystems; 2005 Apr; 80(1):57-69. PubMed ID: 15740835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computation capacities of a broad class of signaling networks are higher than their communication capacities.
    Habibi I; Emamian ES; Simeone O; Abdi A
    Phys Biol; 2019 Oct; 16(6):064001. PubMed ID: 31505478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplistic pathways or complex networks?
    Jørgensen C; Linding R
    Curr Opin Genet Dev; 2010 Feb; 20(1):15-22. PubMed ID: 20096559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational causal reasoning models of mechanisms of androgen stimulation in prostate cancer.
    Pratt D; Hahn W; Matthews A; Febbo P; Berger R; Duckworth B; Levy J; Segaran T; Sun J; Ladd B; Elliston K
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():38. PubMed ID: 17946775
    [No Abstract]   [Full Text] [Related]  

  • 18. Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells.
    Buffard M; Naldi A; Radulescu O; Coopman PJ; Larive RM; Freiss G
    Proteomics; 2019 Nov; 19(21-22):e1800450. PubMed ID: 31472481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity.
    Wynn ML; Ventura AC; Sepulchre JA; García HJ; Merajver SD
    BMC Syst Biol; 2011 Oct; 5():156. PubMed ID: 21970676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Signaling Pathways in Brain Tumors.
    Harrison RA; de Groot JF
    Top Magn Reson Imaging; 2017 Feb; 26(1):15-26. PubMed ID: 28079711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.